Both expression of MAP1LC3A and Beclin 1 in patient is exhibited much lower in immunostaining (Fig. 8A m–q, B) and Western blotting (Fig. 8D) but not vanished indicating possible tendency of lipophagy in development of fatty liver disease. Here, BECN1 is linked to fatty liver disease.